Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - tiamulin as tiamulin hydrogen fumarate - unknown - tiamulin as tiamulin hydrogen fumarate antibiotic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dox-al australia pty ltd - tiamulin as tiamulin hydrogen fumarate - unknown - tiamulin as tiamulin hydrogen fumarate antibiotic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - tiamulin as tiamulin hydrogen fumarate - unknown - tiamulin as tiamulin hydrogen fumarate antibiotic active 0.0 - active constituent

Portugal - English - HMA (Heads of Medicines Agencies)

ceva santé animale - tiamulin 10.12 mg/ml - oral solution - chicken, pigs, turkeys - tiamulin

Ireland - English - HPRA (Health Products Regulatory Authority)

huvepharma nv - tiamulin - solution for injection - 162 milligram(s)/millilitre - tiamulin - porcine - antibacterial

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

elanco malaysia sdn bhd - tiamulin hydrogen fumarate -

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - retapamulin (unii: 4mg6o8991r) (retapamulin - unii:4mg6o8991r) - retapamulin 10 mg in 1 g - altabax is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to staphylococcus aureus (methicillin-susceptible isolates only) or streptococcus pyogenes [see clinical studies (14)] . to reduce the development of drug-resistant bacteria and maintain the effectiveness of altabax and other antibacterial drugs, altabax should none. pregnancy category b . effects on embryo-fetal development were assessed in pregnant rats given 50, 150, or 450 mg/kg/day by oral gavage on days 6 to 17 postcoitus. maternal toxicity (decreased body weight gain and food consumption) and developmental toxicity (decreased fetal body weight and delayed skeletal ossification) were evident at doses ≥150 mg/kg/day. there were no treatment-related malformations observed in fetal rats. retapamulin was given as a continuous intravenous infusion to pregnan

United States - English - NLM (National Library of Medicine)

bimeda, inc. - tiamulin fumarate (unii: ion1q02zcx) (tiamulin - unii:e38wz4u54r) - indications: bimagard™ 12.5% (tiamulin hydrogen fumarate), when administered in the drinking water for five consecutive days, is an effective antibiotic for the treatment of swine dysentery associated with brachyspira (formerly serpulina or treponema ) hyodysenteriae susceptible to tiamulin at a dose level of 3.5 mg tiamulin hydrogen fumarate per pound of body weight daily and for treatment of swine pneumonia due to actinobacillus pleuropneumoniae susceptible to tiamulin when given at 10.5 mg tiamulin hydrogen fumarate per pound of body weight daily. contraindications: swine being treated with bimagard™ 12.5% (tiamulin hydrogen fumarate) should not have access to feeds containing polyether ionophores (e.g. monensin, lasalocid, narasin, salinomycin and semduramicin) as adverse reactions may occur.

United States - English - NLM (National Library of Medicine)

sel biochem xinjiang co., ltd. - tiamulin fumarate (unii: ion1q02zcx) (tiamulin - unii:e38wz4u54r) -

United States - English - NLM (National Library of Medicine)

jiangsu sel biochem co., ltd. - tiamulin fumarate (unii: ion1q02zcx) (tiamulin - unii:e38wz4u54r) -